The effect of Withania somnifera on anxiety symptoms in children with ADHD

Effect of Withania somnifera Root Extract on Anxiety Symptoms in Children with Attention deficite and Hyperactivity Disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180723040567N1

Enrollment

Registered

2018-11-10

Start date

2018-04-05

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention- Deficit Hyperactivity Disorders. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Intervention group: Withania somnifera capsule is orally administered at a dose of 10 mg once daily for 6 weeks. Intervention 2: Control group: The placebo capsule is similar to the

Eligibility

Sex/Gender

All

Age

7 Years to 12 Years

Inclusion criteria

Inclusion criteria: Diagnosis of ADHD based on DSM-5 criteria aged 7-12 years Complete consent form by parent or guardian Normal IQ Symptoms of simultaneous anxiety

Exclusion criteria

Exclusion criteria: The patient's unwillingness to participating in the research project Systemic disease Interventional psychiatric illness intellectual disability

Design outcomes

Primary

Measure	Time frame
Anxiety symptoms in children with ADHD. Timepoint: At the beginning of STUDY and the week 3 and 6. Method of measurement: Child Anxiety Test based on the revised child anxiety scale(RCMA).;Symptoms of ADHD. Timepoint: Weeks 3 and 6. Method of measurement: ADHD rating scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Mohareri

Mashhad University of Medical Sciences

Moharerif1@mums.ac.ir+98 51 3700 2301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026